Literature DB >> 20473866

Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell lines.

Mengsen Li1, Hui Li, Chaoying Li, Shanshan Wang, Wei Jiang, Zhongmin Liu, Sheng Zhou, Xinhua Liu, Michael A McNutt, Gang Li.   

Abstract

Despite its well-defined role as a serum growth factor during fetal liver development and hepatic oncogenesis, the biological significance of cytoplasmic alpha-fetoprotein (AFP) remains incompletely understood. Here, we provide evidence to illustrate that cytoplasmic AFP may function as a regulator in the phosphatidylinositol 3-kinase (PI3K)/AKT pathway in human hepatocellular carcinoma cells. The results demonstrated colocalization and interaction of AFP and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in the cytoplasm of AFP-producing Bel 7402 and HepG2 cells, with an interaction distance of 12.6 ± 2.7 Å as determined with the fluorescence resonance energy transfer technique. Knockdown of AFP mRNA or inhibition of AFP expression by all trans-retinoic acid resulted in enhancement of the PTEN level with a synchronous decrease in phosphorylated AKT. Transfection of the afp gene into HLE cells (originally AFP negative) led to a significant activation of AKT signaling. The inhibition of PI3K signaling by LY 294002 was simultaneously reversed by transfection, accompanied by diminution of all trans-retinoic acid-induced upregulation of PTEN and enhancement of cell growth. In conclusion, these results demonstrate that cytoplasmic AFP is involved in regulation of hepatocellular growth and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20473866     DOI: 10.1002/ijc.25373

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  48 in total

1.  Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma.

Authors:  Peng Li; Shan-Shan Wang; Hui Liu; Ning Li; Michael A McNutt; Gang Li; Hui-Guo Ding
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

Review 2.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

Review 3.  Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer.

Authors:  Martha L Peterson; Chunhong Ma; Brett T Spear
Journal:  Semin Cancer Biol       Date:  2011-01-07       Impact factor: 15.707

4.  Tumor-derived α-fetoprotein impairs the differentiation and T cell stimulatory activity of human dendritic cells.

Authors:  Angela D Pardee; Jian Shi; Lisa H Butterfield
Journal:  J Immunol       Date:  2014-10-29       Impact factor: 5.422

5.  Nonsecreted cytoplasmic alpha-fetoprotein: a newly discovered role in intracellular signaling and regulation. An update and commentary.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2015-07-12

6.  Alpha-fetoprotein contributes to THP-1 cell invasion and chemotaxis via protein kinase and Gi-protein-dependent pathways.

Authors:  Ekaterina Zubkova; Lidiya Semenkova; Elena Dudich; Igor Dudich; Yelena Parfyonova; Mikhail Menshikov
Journal:  Mol Cell Biochem       Date:  2013-04-25       Impact factor: 3.396

Review 7.  Alpha-fetoprotein: a renaissance.

Authors:  A A Terentiev; N T Moldogazieva
Journal:  Tumour Biol       Date:  2013-06-14

8.  A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel.

Authors:  Xiaonan Ji; Yanli Shen; Hao Sun; Xiangdong Gao
Journal:  Tumour Biol       Date:  2016-01-28

Review 9.  Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells.

Authors:  Oleg Shuvalov; Alyona Kizenko; Alexey Petukhov; Olga Fedorova; Alexandra Daks; Nikolai Barlev
Journal:  Cell Death Discov       Date:  2021-05-08

10.  Relationship of α-fetoprotein levels and development of hepatocellular carcinoma in hepatitis C patients with liver cirrhosis.

Authors:  Naota Taura; Sachiko Fukuda; Tatsuki Ichikawa; Hisamitsu Miyaaki; Hidetaka Shibata; Takuya Honda; Tohei Yamaguchi; Yoko Kubota; Shinjiro Uchida; Yasuhiro Kamo; Emi Yoshimura; Hajime Isomoto; Takehiro Matsumoto; Fuminao Takeshima; Takuya Tsutsumi; Shotaro Tsuruta; Kazuhiko Nakao
Journal:  Exp Ther Med       Date:  2012-09-17       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.